Miyajima, C.; Hayakawa, Y.; Inoue, Y.; Nagasaka, M.; Hayashi, H.
HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ. Pharmaceuticals 2022, 15, 1015.
https://doi.org/10.3390/ph15081015
AMA Style
Miyajima C, Hayakawa Y, Inoue Y, Nagasaka M, Hayashi H.
HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ. Pharmaceuticals. 2022; 15(8):1015.
https://doi.org/10.3390/ph15081015
Chicago/Turabian Style
Miyajima, Chiharu, Yurika Hayakawa, Yasumichi Inoue, Mai Nagasaka, and Hidetoshi Hayashi.
2022. "HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ" Pharmaceuticals 15, no. 8: 1015.
https://doi.org/10.3390/ph15081015
APA Style
Miyajima, C., Hayakawa, Y., Inoue, Y., Nagasaka, M., & Hayashi, H.
(2022). HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ. Pharmaceuticals, 15(8), 1015.
https://doi.org/10.3390/ph15081015